コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 vaccine to show potency in the absence of an immunoadjuvant.
2 enhance a murine Th1 response was used as an immunoadjuvant.
3 ding animals that received purified CT as an immunoadjuvant.
4 n when cholera toxin is coadministered as an immunoadjuvant.
5 Both toxins are also potent immunoadjuvants.
6 and the combination can provide significant immunoadjuvant activity even in the vitamin A-adequate s
7 n to inhibiting the development of Treg, the immunoadjuvant activity of PTx can be attributable to th
9 has been increasingly reliant on the use of immunoadjuvants - additives, which can enhance and modul
10 role in activating antitumor immunity as an immunoadjuvant and a local retainer of drug combinations
11 ious studies using glycated chitosan (GC) as immunoadjuvant and indocyanine green (ICG) as laser-abso
13 ed mice with 100 mug of TcpA or TcpA with an immunoadjuvant (cholera toxin [CT], 50 mug) on days 0, 1
16 shock proteins (HSPs) are shown to be strong immunoadjuvants, eliciting both innate and adaptive immu
17 administered TLR5 agonists as organ-specific immunoadjuvants, enabling efficient antitumor vaccinatio
18 ministration of a laser-absorbing dye and an immunoadjuvant, followed by noninvasive laser irradiatio
19 ide a unique platform to co-deliver multiple immunoadjuvants for macrophage therapy to induce systema
21 using a laser, a laser-absorbing dye, and an immunoadjuvant has induced such long-term immunity in tr
24 NF agonist peptide may serve as an important immunoadjuvant in the treatment of murine Klebsiella pne
26 transcutaneous immunization with TcpA and an immunoadjuvant induces protective anti-TcpA immune respo
29 ins supplemented with purified CT as an oral immunoadjuvant or V. cholerae vaccine strains expressing
38 vo and identify this cytokine as a potential immunoadjuvant to be employed in the setting of localize
39 to ascertain whether LT(R192G) can act as an immunoadjuvant when expressed in vivo by V. cholerae, we